Vold Vision P.L.L.C
This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.
To evaluate the range of vision and patient reported outcomes in subjects implanted with Clareon Vivity IOL undergoing concurrent MIGS with the Hydrus Microstent
Inclusion Criteria: * Male or female subjects 45 years of age or older * A visually significant age-related cataract in both eyes * Diagnosis of mild OAG * VF characteristics consistent with glaucoma with mean deviation not worse than -6.00 dB and without fixation threatening scotoma AND/OR with nerve abnormalities consistent with glaucoma (rim notching, rim thinning, disc hemorrhage, nerve fiber layer loss) * Medicated IOP ≤25 mmHg on 1-3 hypotensive medications * Glaucoma must be judged as stable by investigator based on review of subject medical records * Stable VF at least 1 year…
Cataract surgery with implantation of the Vivity IOL along with concurrent implantation of the Hydrus Microstent
Arctuva estimate
Verify or correct the compensation shown for this listing.